Case number 1:23-cv-01340
Harmony Biosciences, LLC et al v. AET Pharma US, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 1, 2024 | N/A | CORRECTING ENTRY: D.I. 48 has been deleted from the docket. All filings are to be made in the lead case (C.A. No. 23-1286) only. (ceg) (Entered: 05/01/2024) (0) |
| Apr 15, 2024 | N/A | Case associated with lead case: Create association to 1:23-cv-01286-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:23-cv-01286-JLH ONLY. (ceg) (Entered: 04/15/2024) (0) |
| Apr 15, 2024 | 47 | SCHEDULING AND CONSOLIDATION ORDER: Harmony Biosciences, LLC et al. v. Lupin Limited et al., C.A. No. 23-1286-JLH, Harmony Biosciences, LLC et al. v. AET Pharma US, Inc. et al., C.A. No. 23-1340-JLH, and Harmony Biosciences, LLC et al. v. MSN Pharms. Inc. et al., C.A. No. 23-1420-JLH, are consolidated for all purposes up to and including trial. Joinder of Parties due by 8/30/2024. Amended Pleadings due by 8/30/2024. Joint Claim Construction Brief due by 1/8/2025. A Markman Hearing is set for 3/27/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Interim Status Report due by 4/2/2025. Fact Discovery completed by 4/18/2025. Expert Discovery completed by 10/30/2025. Proposed Pretrial Order due by 1/14/2026. A Pretrial Conference is set for 1/21/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. A 4-day Bench Trial is set for 2/17/2026 at 09:30 AM in Courtroom 6D before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 4/15/2024. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH(ceg) (Entered: 04/15/2024) (17) |
| Apr 8, 2024 | 46 | Joint PROPOSED Scheduling and Order re (23 in 1:23-cv-01420-JLH), (36 in 1:23-cv-01340-JLH), (27 in 1:23-cv-01286-JLH) Order, by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche. (Attachments: # 1 Cover Letter to the Honorable Jennifer L. Hall)(Tigan, Jeremy) Modified on 4/8/2024 (ceg). (Entered: 04/08/2024) (0) |
| Apr 5, 2024 | 45 | SO ORDERED, re (44 in 1:23-cv-01340-JLH, 29 in 1:23-cv-01286-JLH, 27 in 1:23-cv-01420-JLH) Stipulation and Order to Extend Time for the parties to file a joint proposed scheduling order and letter to April 8, 2024. Signed by Judge Jennifer L. Hall on 4/5/2024. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH(ceg) (Entered: 04/05/2024) (3) |
| Apr 4, 2024 | 44 | STIPULATION TO EXTEND TIME for the parties to file a joint proposed scheduling order and letter pursuant to the Court's Oral Orders (C.A. No. 23-1286, D.I. 27; C.A. No. 23-1340, D.I. 36; C.A. No. 23-1420, D.I. 23) to April 8, 2024 - filed by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche. (Tigan, Jeremy) (Entered: 04/04/2024) (3) |
| Mar 25, 2024 | 43 | ANSWER to 38 Annora Pharma Private Limited's Answer to Complaint, Counterclaim, by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) Modified on 3/25/2024 (ceg). (Entered: 03/25/2024) (16) |
| Mar 12, 2024 | 42 | SO ORDERED, re (41 in 1:23-cv-01340-JLH, 24 in 1:23-cv-01420-JLH) Stipulation and Order to Extend Time for the parties to file a proposed scheduling order and letter to April 4, 2024. Signed by Judge Jennifer L. Hall on 3/12/2024. Associated Cases: 1:23-cv-01340-JLH, 1:23-cv-01420-JLH(ceg) (Entered: 03/12/2024) (3) |
| Mar 12, 2024 | 41 | STIPULATION TO EXTEND TIME for the parties to file a proposed scheduling order and letter pursuant to the Court's Oral Orders (C.A. No. 23-1340, D.I. 36; C.A. No. 23-1420, D.I. 23) to April 4, 2024 - filed by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche. (Tigan, Jeremy) (Entered: 03/12/2024) (3) |
| Mar 7, 2024 | 40 | ANSWER to 33 Answer to Complaint, Counterclaim, -- Plaintiffs' Answer to Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd's Counterclaims -- by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) Modified on 3/7/2024 (ceg). (Entered: 03/07/2024) (12) |
| Mar 4, 2024 | 39 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd. for Annora Pharma Private Limited filed by Annora Pharma Private Limited. (Cramer, Kristen) (Entered: 03/04/2024) (3) |
| Mar 4, 2024 | 38 | ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs by Annora Pharma Private Limited. (Cramer, Kristen) Modified on 3/5/2024 (ceg). (Entered: 03/04/2024) (30) |
| Feb 23, 2024 | 37 | ANSWER to 28 Answer to Complaint, Counterclaim -- Plaintiffs' Answer to AET Pharma US, Inc.'s Counterclaims -- by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 02/23/2024) (12) |
| Feb 21, 2024 | 36 | ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) the parties' positions regarding any disputes in the proposed Scheduling Order and (b) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 2/21/2024. (ceg) (Entered: 02/21/2024) (0) |
| Feb 16, 2024 | 35 | ANSWER to 24 Answer to Complaint, Counterclaim -- Plaintiffs' Answer to Novitium Pharma LLC's Counterclaims -- by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 02/16/2024) (15) |
| Feb 15, 2024 | 34 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Limited filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. (Weinblatt, Richard) (Entered: 02/15/2024) (2) |
| Feb 15, 2024 | 33 | ANSWER to 1 Complaint, COUNTERCLAIM against Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. (Weinblatt, Richard) Modified on 2/16/2024 (ceg). (Entered: 02/15/2024) (30) |
| Feb 6, 2024 | N/A | Pro Hac Vice Attorneys Elana B. Araj, Jonathan D. Ball, and Giancarlo Scaccia for AET Pharma US, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/06/2024) (0) |
| Feb 6, 2024 | 32 | NOTICE of Appearance by Kristen Healey Cramer on behalf of Annora Pharma Private Limited (Cramer, Kristen) (Entered: 02/06/2024) (1) |
| Feb 5, 2024 | N/A | Pro Hac Vice Attorney Scott J. Bornstein for AET Pharma US, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 02/05/2024) (0) |
| Feb 5, 2024 | N/A | Pro Hac Vice Attorney Julie P. Bookbinder for AET Pharma US, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 02/05/2024) (0) |
| Feb 2, 2024 | N/A | SO ORDERED, re 31 Motion for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan D. Ball, Ph.D., Julie P. Bookbinder, Elana B. Araj and Giancarlo Scaccia of Greenberg Traurig, LLP filed by AET Pharma US, Inc. Ordered by Judge Jennifer L. Hall on 2/2/2024. (ceg) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 31 | MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Jonathan D. Ball, Ph.D., Julie P. Bookbinder, Elana B. Araj and Giancarlo Scaccia of Greenberg Traurig, LLP - filed by AET Pharma US, Inc.. (Gattuso, Dominick) (Entered: 02/02/2024) (8) |
| Feb 2, 2024 | 30 | Pro Hac Vice Fee - Credit Card Payment received for Scott J. Bornstein, Jonathan D. Ball, Ph.D., Julie P. Bookbinder, Elana B. Araj, and Giancarlo Scaccia. ( Payment of $ 250, receipt number ADEDC-4329725).(Gattuso, Dominick) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 29 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Tieffenbacher Group for AET Pharma US, Inc. filed by AET Pharma US, Inc.. (Gattuso, Dominick) (Entered: 02/02/2024) (2) |
| Feb 2, 2024 | 28 | ANSWER to 1 Complaint, COUNTERCLAIM against All Plaintiffs by AET Pharma US, Inc. (Gattuso, Dominick) Modified on 2/16/2024 (ceg). (Entered: 02/02/2024) (30) |
| Jan 31, 2024 | N/A | Pro Hac Vice Attorneys Ricardo S. Camposanto, Aaron Z. Savit, and Aziz Burgy for Novitium Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/31/2024) (0) |
| Jan 31, 2024 | N/A | SO ORDERED, re 26 Motion for Pro Hac Vice Appearance of Attorney Aziz Burgy, Esquire, Ricardo S. Camposanto, Esquire, and Aaron Z. Savit, Esquire filed by Novitium Pharma LLC. Ordered by Judge Jennifer L. Hall on 1/31/2024. (ceg) (Entered: 01/31/2024) (0) |
| Jan 30, 2024 | 27 | Pro Hac Vice Fee - Credit Card Payment received for Aziz Burgy, Esquire, Ricardo S. Camposanto, Esquire, and Aaron Z. Savit, Esquire. ( re 26 MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy, Esquire, Ricardo S. Camposanto, Esquire, and Aaron Z. Savit, Esquire )( Payment of $ 150, receipt number ADEDC-4326158).(Stombaugh, Alexis) (Entered: 01/30/2024) (0) |
| Jan 30, 2024 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy, Esquire, Ricardo S. Camposanto, Esquire, and Aaron Z. Savit, Esquire - filed by Novitium Pharma LLC. (Stombaugh, Alexis) (Entered: 01/30/2024) (6) |
| Jan 30, 2024 | N/A | Pro Hac Vice Attorney Michael S. Weinstein for Annora Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/30/2024) (0) |
| Jan 29, 2024 | 25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent ANI Pharmaceuticals, Inc., Other Affiliate BlackRock, Inc. for Novitium Pharma LLC filed by Novitium Pharma LLC. (Gaza, Anne) (Entered: 01/29/2024) (3) |
| Jan 29, 2024 | 24 | ANSWER to 1 Complaint, , COUNTERCLAIM against Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC by Novitium Pharma LLC.(Gaza, Anne) (Entered: 01/29/2024) (30) |
| Jan 9, 2024 | N/A | Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH (rjb) (Entered: 01/09/2024) (0) |
| Jan 9, 2024 | N/A | Pro Hac Vice Attorney Hayk Snkhchyan for Annora Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/09/2024) (0) |
| Jan 5, 2024 | N/A | Pro Hac Vice Attorney Charanjit Brahma for Annora Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 01/05/2024) (0) |
| Jan 5, 2024 | N/A | Pro Hac Vice Attorney Timothy P. Heaton for Annora Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/05/2024) (0) |
| Jan 4, 2024 | N/A | Pro Hac Vice Attorney Samuel J. Ruggio for Annora Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/04/2024) (0) |
| Jan 3, 2024 | N/A | SO ORDERED re 20 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein, 21 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio, 18 MOTION for Pro Hac Vice Appearance of Attorney Charanjit Brahma, 22 MOTION for Pro Hac Vice Appearance of Attorney Timothy P. Heaton, 19 MOTION for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan filed by Annora Pharma Private Limited. ORDERED by Judge Maryellen Noreika on 1/3/2024. (dlw) (Entered: 01/03/2024) (0) |
| Jan 3, 2024 | 23 | Pro Hac Vice Fee - Credit Card Payment received for Charanjit Brahma, Michael S. Weinstein, Hayk Snkhchyan, Samuel J. Ruggio, and Timothy P. Heaton. ( re 20 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein, 21 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio, 18 MOTION for Pro Hac Vice Appearance of Attorney Charanjit Brahma, 22 MOTION for Pro Hac Vice Appearance of Attorney Timothy P. Heaton, 19 MOTION for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan )( Payment of $ 250, receipt number ADEDC-4306003).(Capuzzi, Kevin) (Entered: 01/03/2024) (0) |
| Jan 3, 2024 | 22 | MOTION for Pro Hac Vice Appearance of Attorney Timothy P. Heaton - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) (Entered: 01/03/2024) (4) |
| Jan 3, 2024 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) (Entered: 01/03/2024) (4) |
| Jan 3, 2024 | 20 | MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) (Entered: 01/03/2024) (4) |
| Jan 3, 2024 | 19 | MOTION for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) (Entered: 01/03/2024) (4) |
| Jan 3, 2024 | 18 | MOTION for Pro Hac Vice Appearance of Attorney Charanjit Brahma - filed by Annora Pharma Private Limited. (Capuzzi, Kevin) (Entered: 01/03/2024) (4) |
| Jan 2, 2024 | 17 | SO ORDERED re 16 Stipulation and Order Dismissing Defendants Hetero USA, Inc. and Hetero Labs Limited Without Prejudice and Amending Caption to Reflect Same. Party Hetero Labs Limited and Hetero USA, Inc. terminated. Attorney Kevin M. Capuzzi and Noelle Briana Torrice terminated as to these Defendants. Signed by Judge Maryellen Noreika on 1/2/2024. (dlw) (Entered: 01/02/2024) (5) |
| Dec 27, 2023 | 16 | STIPULATION and [Proposed] Order Dismissing Defendants Hetero USA, Inc. and Hetero Labs Limited Without Prejudice and Amending Caption to Reflect Same - by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 12/27/2023) (5) |
| Dec 21, 2023 | N/A | SO ORDERED re (15 in 1:23-cv-01340-MN, 17 in 1:23-cv-01286-MN) MOTION for Pro Hac Vice Appearance of Attorney Pierre Anquetil filed by Harmony Biosciences, LLC, Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche. ORDERED by Judge Maryellen Noreika on 12/21/2023. (dlw) (Entered: 12/21/2023) (0) |
| Dec 21, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Pierre Anquetil - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 12/21/2023) (5) |
| Dec 19, 2023 | N/A | Pro Hac Vice Attorney Yixin H. Tang for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/19/2023) (0) |
| Dec 7, 2023 | 14 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For AET Pharma US, Inc. waiver sent on 12/4/2023, answer due 2/2/2024. (Tigan, Jeremy) (Entered: 12/07/2023) (1) |
| Dec 7, 2023 | N/A | SO ORDERED re (12 in 1:23-cv-01286-MN, 13 in 1:23-cv-01340-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, and Yiye Fu filed by Harmony Biosciences, LLC, Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche. ORDERED by Judge Maryellen Noreika on 12/7/2023. (dlw) (Entered: 12/07/2023) (0) |
| Dec 6, 2023 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, and Yiye Fu - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 12/06/2023) (9) |
| Dec 5, 2023 | N/A | Pro Hac Vice Attorney Shashank D. Upadhye for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/05/2023) (0) |
| Dec 5, 2023 | N/A | Pro Hac Vice Attorney Brent A. Batzer for Biophore India Pharmaceuticals Private Limited and Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/05/2023) (0) |
| Dec 1, 2023 | N/A | SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. Ordered by Judge Maryellen Noreika on 12/1/2023. (as) (Entered: 12/01/2023) (0) |
| Nov 30, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, and Brent Batzer - filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. (Weinblatt, Richard) (Entered: 11/30/2023) (7) |
| Nov 30, 2023 | 11 | NOTICE of Appearance by Richard Charles Weinblatt on behalf of Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited (Weinblatt, Richard) (Entered: 11/30/2023) (3) |
| Nov 30, 2023 | 10 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For Novitium Pharma LLC waiver sent on 11/29/2023, answer due 1/29/2024. (Tigan, Jeremy) (Entered: 11/30/2023) (1) |
| Nov 30, 2023 | 9 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For Zenara Pharma Private Limited waiver sent on 11/28/2023, answer due 2/26/2024. (Tigan, Jeremy) (Entered: 11/30/2023) (1) |
| Nov 30, 2023 | 8 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For Biophore India Pharmaceuticals Private Limited waiver sent on 11/28/2023, answer due 2/26/2024. (Tigan, Jeremy) (Entered: 11/30/2023) (1) |
| Nov 29, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 11/29/2023) (0) |
| Nov 21, 2023 | 7 | Summons Issued as to AET Pharma US, Inc.; Annora Pharma Private Limited; Biophore India Pharmaceuticals Private Limited; Hetero Labs Limited; Hetero USA, Inc.; Novitium Pharma LLC; Zenara Pharma Private Limited on 11/22/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued, # 4 Summons Issued, # 5 Summons Issued, # 6 Summons Issued)(twk) (Entered: 11/22/2023) (0) |
| Nov 21, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bioprojet Societe Civile de Recherche for Bioprojet Pharma SAS filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche. (twk) (Entered: 11/22/2023) (2) |
| Nov 21, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Harmony Biosciences Holdings, Inc. for Harmony Biosciences, LLC filed by Harmony Biosciences, LLC. (twk) (Entered: 11/22/2023) (2) |
| Nov 21, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,947 B2; 8,207,197 B2; 8,354,430 B2. (twk) (Entered: 11/22/2023) (1) |
| Nov 21, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than October 13, 2023. Date of Expiration of Patent: U.S. Patent No. 8,486,947 expires on September 26, 2029; U.S. Patent No. 8,207,197 expires on March 7, 2030; U.S. Patent No. 8,354,430 expires on February 6, 2026. Thirty Month Stay Deadline: 2/14/2027. (twk) (Entered: 11/22/2023) (1) |
| Nov 21, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 11/22/2023) (3) |
| Nov 21, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against AET Pharma US, Inc., Annora Pharma Private Limited, Biophore India Pharmaceuticals Private Limited, Hetero Labs Limited, Hetero USA, Inc., Novitium Pharma LLC, Zenara Pharma Private Limited ( Filing fee $ 402, receipt number ADEDC-4279102.) - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(twk) (Entered: 11/22/2023) (0) |
